As of 2025-09-18, the Intrinsic Value of Vor Biopharma Inc (VOR) is -65.69 USD. This VOR valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.52 USD, the upside of Vor Biopharma Inc is -4,421.97%.
Based on its market price of 1.52 USD and our intrinsic valuation, Vor Biopharma Inc (VOR) is overvalued by 4,421.97%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -65.69 - -65.69 | -65.69 | -4,421.97% |
| P/E | (182.63) - (177.37) | (177.05) | -11747.8% |
| DDM - Stable | (121.70) - (451.05) | (286.38) | -18940.5% |
| DDM - Multi | (0.14) - (0.38) | (0.20) | -113.3% |
| Market Cap (mil) | 192.55 |
| Beta | 6.13 |
| Outstanding shares (mil) | 126.68 |
| Enterprise Value (mil) | 1.98 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.09% |
| Cost of Debt | 5.00% |
| WACC | 6.38% |